AI-generated summary
The authors studied bone marrow stem cells from diabetic rats that were grown into bone-forming cells and then treated with red light (660 nm) every 72 hours. They report that the treatment improved cell viability, increased bone-related gene and protein expression, and raised alkaline phosphatase activity and mineralized matrix production compared with untreated cells. These are laboratory cell results only.
- Who or what was studied
- Bone marrow mesenchymal stem cells isolated from healthy rats and from rats with induced diabetes mellitus, differentiated into osteoblasts
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was performed on rat cells in culture, so the abstract does not show effects in living animals or patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 5 J/cm2
- Power
- 20 mW
- Total energy
- 0.14 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.